logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

The Future Of Hiv1 Therapeutics Resistance Is Futile 1st Edition Bruce E Torbett

  • SKU: BELL-5141386
The Future Of Hiv1 Therapeutics Resistance Is Futile 1st Edition Bruce E Torbett
$ 31.00 $ 45.00 (-31%)

4.3

98 reviews

The Future Of Hiv1 Therapeutics Resistance Is Futile 1st Edition Bruce E Torbett instant download after payment.

Publisher: Springer International Publishing
File Extension: PDF
File size: 6.75 MB
Pages: 254
Author: Bruce E. Torbett, David S. Goodsell, Douglas D. Richman (eds.)
ISBN: 9783319185170, 3319185179
Language: English
Year: 2015
Edition: 1

Product desciption

The Future Of Hiv1 Therapeutics Resistance Is Futile 1st Edition Bruce E Torbett by Bruce E. Torbett, David S. Goodsell, Douglas D. Richman (eds.) 9783319185170, 3319185179 instant download after payment.

This volume thoroughly covers HIV-1 antiretrovirals currently in clinical use, together with their advantages and limitations. HIV-1 inhibitor resistance is discussed in detail, and critical assessments as to what will be required of future antiretrovirals in order to halt viral replication, reduce viral resistance, and alter the state of viral latency are presented. Experts at the forefront of HIV-1 research provide overviews of approaches from the fields of virology, chemical biology and structural biology for obtaining small molecule inhibitors that target viral regulatory and structural components at multiple points in the viral lifecycle. The individual chapters will appeal to scientists and clinicians alike.

Related Products